Champions Oncology (CSBR) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026)
Champions Oncology (CSBR) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -99.85% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.70% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 10.87% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 70.79% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 19.14% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Champions Oncology | 68.61 Mn | 68.61 Mn | 7.03 Mn | -19.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -19.41% |
| Jan 31, 2026 | -26.49% |
| Oct 31, 2025 | -20.46% |
| Jul 31, 2025 | -19.76% |
| Apr 30, 2025 | -23.53% |
| Jan 31, 2025 | -22.85% |
| Oct 31, 2024 | -28.44% |
| Jul 31, 2024 | -28.50% |
| Apr 30, 2024 | -20.39% |
| Jan 31, 2024 | -16.80% |
| Oct 31, 2023 | -9.95% |
| Jul 31, 2023 | -4.22% |
| Apr 30, 2023 | 0.73% |
| Jan 31, 2023 | 12.32% |
| Oct 31, 2022 | 10.38% |
| Jul 31, 2022 | 13.83% |
| Apr 30, 2022 | 17.14% |
| Jan 31, 2022 | 26.19% |
| Oct 31, 2021 | 43.33% |
| Jul 31, 2021 | 52.53% |